SWP
ABMD

Stratos Wealth Partners’s Abiomed Inc ABMD Stock Holding History

Stratos Wealth Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,006
Closed -$279K – 1117
2020
Q3 		$279K Buy
+1,006
New +$290K 0.01% 815
2018
Q2 		– Sell
-404
Closed -$118K – 2788
2018
Q1 		$118K Sell
404
-320
-44% -$81.1K 0.01% 1116
2017
Q4 		$136K Buy
+724
New +$135K 0.01% 1028

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Stratos Wealth Partners's ABMD Position: Q4 2020 in Review

Stratos Wealth Partners sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 1,006 shares — an estimated $279K sold.

Stratos Wealth Partners first reported a position in ABMD in Q4 2017 and held it in 3 quarters. The position peaked at $279K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Stratos Wealth Partners reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,006 Abiomed Inc shares in Q4 2020, an estimated $279K.
  • Stratos Wealth Partners first reported a position in Abiomed Inc in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Abiomed Inc position peaked at $279K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Stratos Wealth Partners's 13F filing for Q4 2020, filed 29 Jan 2021.